SEC Form 5 · accession 0001209191-15-013822
CORCEPT THERAPEUTICS INC · CORT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James N Wilson
Director
Period of report
Dec 31, 2014
Accepted (ET)
Feb 13, 2015 · 6:23 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001088856
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Dec 17, 2013 | G | 52,295 | $0.00 | D | 1,902,216 | D | |
| Common stock | Dec 26, 2013 | G | 57,420 | $0.00 | D | 1,844,796 | D | |
| Common stock | Jan 30, 2014 | G | 68,400 | $0.00 | D | 1,776,396 | D | |
| Common stock | Dec 29, 2014 | G | 75,000 | $0.00 | D | 1,701,396 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares distributed by gift to family members of the Reporting Person.